About Us

About IntegReview IRB

About IntegReview IRB - About Us

IntegReview IRB is an independent institutional review board that provides ethical review to approve, and conduct periodic review of biomedical, medical device, social, educational and behavioral research involving human subjects in the United States, Latin America and Japan.

Integreview IRB is dedicated to providing unsurpassed ethical review services. The ethical principles employed by IntegReview IRB that govern the conduct of human research are those identified in the Belmont Report:respect for persons, beneficence and justice.

IntegReview is also known as an independent ethics committee (IEC) or ethical review board (ERB).

The Food and Drug Administration (FDA) and Office for Human Research Protections (OHRP) have empowered IRBs to approve, require modifications in planned research prior to approval, or disapprove research. IRBs are responsible for critical oversight functions for research conducted on human subjects that are scientific, ethical, and regulatory.

IntegReview IRB complies with the regulations as defined in the United States Food and Drug Administration (FDA), Code of Federal Regulations, Title 21, Parts 50, 54, 56, 312 and 812, International Conference on Harmonisation (ICH) Guidelines for Good Clinical Practices, E6, the Department of Health and Human Services (DHHS) regulations as identified in the Code of Federal Regulations, Title 45, Part 46, other regulations as applicable, as well as local and state laws.

IntegReview offers IRB review of the following types of research

IntegReview offers IRB review of the following types of research - About Us
  • Phase I-IV biomedical research
  • Medical device research
  • Social, educational and behavioral research
  • Stem cell research
  • Investigator-sponsored research
  • Single investigator research
  • Multiple investigator research
  • Research conducted in academic and hospital settings
  • Emergency resarch
  • Expedited review of research that qualifies, as identified in the Federal Register
  • Expedited review of Investigators involved in multiple-investigator studies
  • Projects that may be exempt from federal regulations
  • Research conducted in Latin America
  • Research conducted in Japan
  • IntegReview collaborates with a Canadian-based IRB to conduct Canadian site reviews and provide oversight